The sea water nasal spray market is expected to grow from US$ 2,563.60 million in 2022 to US$ 3,812.22 million by 2030; the market is estimated to record a CAGR of 5.7% from 2022 to 2030.

The report highlights prevailing trends and factors driving the market growth. The market growth is attributed to the increase in infection and allergic cases and the growing patient preference for nasal drug delivery due to easy administration and better efficacy. However, regulatory hurdles restrain the market growth.

Nasal sprays help deliver the drug through the nose in the nasal cavity to treat allergies and other problems related to brain inflammation, diabetes, dental problems, and the central nervous system. Allergy is a condition in which the body's immune system reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients.

Different types of nasal sprays are available in the market, such as decongestion nasal spray, saline nasal spray, and steroid nasal spray. Decongestants are devices with drugs for treating nasal congestion and providing short-term relief from a blocked nose. Decongestion nasal sprays consist of drugs that open up the airways of the nasal part and help in the breathing process.

During the cold and dry winter season, saline nasal sprays are used to avoid problems related to a stuffy nose. These devices are used to treat sinusitis, nasal crusting, and thin secretions of liquid from the nose, which are formed due to bacterial infection and lead to the dryness of the nasal area. This device helps clean the nasal passage and mucus in that area due to cold.

Nasal hygiene can be maintained by regular irrigation using saline solutions, which help eliminate excess secretions, pollutants, pathogens, and allergens accumulating in the nasal cavity, reduce congestion, and moisturize the nose. Utilization of saline solutions for nasal irrigation is easy to use, well tolerated, and effective for nasal hygiene. For example, in children, saline nasal irrigation has been shown to re-establish the nasal permeability of post-rhinitis and prevent the recurrence of cold and flu and nasal congestion. Another clinical trial in children with allergic rhinitis has concluded that nasal saline irrigation may be a good adjunctive treatment option. Using nasal irrigation decreases the use of topical steroids for controlling allergic rhinitis in children, which may eventually lessen the condition's side effects and economic burden. Indeed, nasal irrigation with saline solutions is recommended as an adjunct therapy for the common cold, acute and chronic rhinosinusitis, and allergic rhinitis, alleviating sinonasal symptoms.

Saline solutions can be obtained by diluting seawater and used for nasal irrigation at isotonic concentration (0.9% NaCl), equal to Na+ and Cl? ions in the human body. Early in the twentieth century, microfiltered diluted ocean water (or "marine plasma") was shown to have an identical ionic balance to blood serum and interstitial fluid. In addition to sodium and chloride, diluted seawater contains the full spectrum of minerals and trace elements in human plasma, such as potassium, calcium, and magnesium. Studies have demonstrated the beneficial role of diluted seawater over classic saline solution preparations for nasal irrigation.

Due to the advantages of nasal sprays, pharmaceutical, and biotechnology companies have increased their investment in research and development to develop new nasal spray products to treat diseases such as infectious diseases or CNS disorders. For instance, in March 2023, Pfizer received FDA approval for Zavzpret, a nasal spray used to treat migraines. In March 2019, Janssen Pharmaceuticals Sparvato (ketamine) got FDA approval. It is a nasal spray used by adult patients with treatment-resistant depression. Thus, pharmaceutical companies are increasingly focusing on developing new nasal spray products to treat various diseases. Improved healthcare infrastructure, increased healthcare expenditures, and R&D funding will propel the market growth.

Report Segmentation and Scope -

The "Sea water nasal spray market" is segmented based on type, application, and distribution channel. Based on type, the sea water nasal spray market is categorized into isotonic sea water nasal spray, hypertonic sea water nasal spray, and hypotonic sea water nasal spray. Based on application, the sea water nasal spray market is segmented into infants, children, and adults. Based on the distributional channel, the sea water nasal spray market is segmented into hospital pharmacies, drug stores, and online pharmacies.

Based on type, the sea water nasal spray market is segmented into isotonic sea water nasal spray, hypertonic sea water nasal spray, and hypotonic sea water nasal spray. In 2022, the hypertonic sea water nasal spray segment held the largest market share and is expected to register the highest CAGR from 2022 to 2030. Physicians recommend hypertonic nasal spray due to the higher concentration of salt that may draw fluid and mucus out more effectively.

Based on the application, the sea water nasal spray market is categorized into infants, children, and adults. The children's and adults segment held the largest share of the market in 2022 and is projected to register the highest CAGR from 2022 to 2030.

Based on the distributional channel, the sea water nasal spray market is categorized into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2022 and is projected to register the highest CAGR from 2022 to 2030.

The United States Food and Drug Administration (FDA), The Endocrine Society, and the National Institutes of Health (NIH) are a few of the major primary and secondary sources referred to while preparing the report on the seawater nasal spray market.